Clinical Trial Update: Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL) [Phase 2]

View source ↗

Summary

A Phase 2 multicenter trial comparing Taxotere (docetaxel) plus Curcumin versus Taxotere plus placebo in first-line treatment of metastatic castration-resistant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Curcumin (curcumin)
• Taxotere (docetaxel)

Snippet

Sponsor: Centre Jean Perrin | Conditions: Prostate Cancer Metastatic Castration Resistant | Phase 2 | Status: TERMINATED